Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Mechanical Force Spurs Blood Clotting at Molecular Scale

By John Toon, Georgia Tech | August 16, 2016

Researchers Lining (Arnold) Ju, Cheng Zhu (seated) and Yunfeng Chen are shown with the single-molecule force measurement tool used to study how platelets sense the mechanical forces they encounter during bleeding. Image: John Toon, Georgia Tech

Using a unique single-molecule force measurement tool, a research team has developed a clearer understanding of how platelets sense the mechanical forces they encounter during bleeding to initiate the cascading process that leads to blood clotting.

Beyond providing a better understanding of this vital bodily process, research into a mechanoreceptor molecule that triggers clotting could provide a potential new target for therapeutic intervention. Excessive clotting can lead to heart attack and stroke — major killers worldwide — while insufficient clotting allows life-threatening bleeding.

“We have opened a new door to study how mechanical force triggers biochemical signals inside living cells,” says Lining (Arnold) Ju, who was part of the team conducting the research as a Ph.D. student in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.

Now a postdoctoral researcher at the University of Sydney and the Heart Research Institute, Ju worked with Georgia Tech graduate student Yunfeng Chen, to conduct the research in the laboratory of Professor Cheng Zhu in the Coulter Department. Also part of the research were Lingzhou Xue from Penn State University and Xiaoping Du from the University of Illinois at Chicago.

The research, supported by the National Institutes of Health and the National Science Foundation, was reported in the journal eLife. It is believed to be the first detailed mechanobiology study on how mechanical forces acting on a single molecule on a platelet are sensed and transduced into biochemical signals. Beyond blood clotting, the work could have implications for other cellular systems that respond to mechanical force.

In the beginning of the clotting process, human platelets use a highly specialized molecule known as glycoprotein Ibα (GPIbα) to receive mechanical signals. In a process known as mechanosensing, the mechanical information is converted into chemical signals — the release of different types of calcium ions — that alter adhesion between platelets and other components of the clotting process. Using their unique experimental equipment, the research team correlated various forces applied to the GPIbα molecule with different chemical signals, working to understand the operation of this natural transducer built into human platelets.

How cells sense their mechanical environment and transduce forces into biochemical signals is a crucial, yet unresolved question in mechanobiology, the researchers noted in their paper. The researchers studied how mechanical forces outside the platelets trigger the release of calcium ions inside the cells. They applied force on the GPIbα molecule via the binding of von Willebrand factor and a mutant form of this plasma protein that causes von Willibrand Disease, a bleeding disorder.

The researchers observed two distinct mechanical events: the unfolding of two geometrically separate domains of GPIbα. They discovered that these two events occur synergistically to relay the information about the forces acting on GPIbα, allowing the molecule to sense both the magnitude of the force and how long it is exerted.

The two unfolding events play distinct roles in determining the quantity and quality of the signals — the strength and types of calcium ions fired by the platelet. The strength of the signal is related to the duration of the force, noted Chen, who recently obtained a Ph.D. in bioengineering and will soon be a postdoctoral fellow at The Scripps Research Institute at La Jolla, Calif.

“The GPlbα molecule is bound to and pulled by the von Willebrand factor, which is prolonged by unfolding of one GPIbα domain,” he says. “But the strong signal type always follows the unfolding of the other GPIbα domain, which is enhanced by prolonged pulling at a high force,” Chen adds. “These properties generate cooperativity — a synergistic effect that results in the highest signaling quantity and quality at an optimal force where it lasts the longest.”

However, the researchers discovered that the von Willebrand factor mutation associated with Type 2B von Willibrand Disease abolishes the synergy between the two unfolding events, preventing the GPIbα molecule from efficiently transducing mechanical signals into biochemical signals.

“For years, researchers had thought that the problem was solely the defect in platelet adhesion,” says Zhu. “But our research reveals another defect: the mechano-sensing machinery doesn’t work well in the presence of this mutation. The platelet just doesn’t get the signal that would activate it.”

That knowledge could potentially lead to new treatments for the mutation, and for new drugs to help control clotting.

“We have provided some molecular evidence to suggest under what scenarios the platelet will respond abnormally,” says Ju. “We hope that this could be a target for a new therapeutic agent for treatment of biomechanical thrombosis. We have provided some new molecular insights into this process.”

The unique nanotool developed by the researchers is known as the fluorescence biomembrane force probe. The probe uses a red blood cell to apply force to a single molecule on a platelet. While force is being applied, the researchers can examine the change in calcium ions released inside the platelet by fluorescence. The ability for such concurrent measurement is key to uncovering the GPIbα mechanosensing mechanism on a live platelet.

“In this work, we visualized the conformational changes in a single protein and the subsequent signaling event inside a cell at the same time” explains Ju. “A GPlbα molecule on the platelet surface was unfolded when we pulled on it with a force on the scale of piconewtons. That molecular conformational change triggers the calcium ion release in platelets instructing them to become more adhesive and more reactive.”

The two GPIbα domains studied by the researchers exist widely in many protein families. The methods developed by Ju and collaborators in this work can be used to analyze mechano-sensing in other biological systems.

Source: Georgia Tech

Related Articles Read More >

Big Tech now spends almost 3x more on R&D than Big Pharma 
Inside the Lab: NARI’s Ga-68 Dolacga measures liver function CT scans can’t see
Verily secures new investment from Nvidia
How Lantern Med Digital is helping build the digital layer of Costa Rica’s medtech boom
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE